Literature DB >> 23838588

Health-related quality of life in childhood cancer.

Hala Fakhry1, Matthew Goldenberg, Gregory Sayer, San San Aye, Kara Bagot, Sarah Pi, Rassil Ghazzaoui, Ngoctram Vo, Shanthi Gowrinathan, Michael Bolton, Waguih William IsHak.   

Abstract

OBJECTIVE: Health-related quality of life (HRQoL) has become an increasingly important measure of research and treatment outcomes across all medical specialties. However, to date, there has not been an in-depth review of research relevant specifically to HRQoL in the populations of children and adolescents with cancer. In this review, the authors examine the effects of cancer on HRQoL from diagnosis to remission/survivorship and the end of life.
DESIGN: A literature search was conducted using Medline and PsycINFO for articles published from 2002 to 2011. Studies included patients from diagnosis to remission and also the terminally ill. Twenty-nine studies specifically addressing HRQoL were selected after reaching consensus and study quality check.
RESULTS: Children who are newly diagnosed with cancer and are undergoing treatment or are terminally ill have impaired HRQoL. Survivors of childhood cancer have high HRQoL (with the exception of those who experienced medical comorbidity or PTSD). The authors found that demographic differences, cancer types, and treatment regimens, all significantly influence the negative impact of cancer on patients' HRQoL.
CONCLUSIONS: There are specific and identifiable impacts of childhood cancer on patients' HRQoL that are significant and complex across the span of the illness. There is a need for continued research in many areas related to this population, especially related to those with terminal illness in order to improve patient care.

Entities:  

Mesh:

Year:  2013        PMID: 23838588     DOI: 10.1097/DBP.0b013e31828c5fa6

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN: 0196-206X            Impact factor:   2.225


  8 in total

1.  Pharmacogenomics in Children.

Authors:  Michael J Rieder; Abdelbaset A Elzagallaai
Journal:  Methods Mol Biol       Date:  2022

2.  Quality of Life in Children With Advanced Cancer: A Report From the PediQUEST Study.

Authors:  Abby R Rosenberg; Liliana Orellana; Christina Ullrich; Tammy Kang; J Russell Geyer; Chris Feudtner; Veronica Dussel; Joanne Wolfe
Journal:  J Pain Symptom Manage       Date:  2016-05-21       Impact factor: 3.612

Review 3.  Pharmacogenomics and adverse drug reactions in children.

Authors:  Michael J Rieder; Bruce Carleton
Journal:  Front Genet       Date:  2014-04-16       Impact factor: 4.599

4.  Differences in Adverse Drug Events Among Pediatric Patients With and Without Cancer: Sub-Analysis of a Retrospective Cohort Study.

Authors:  Akira Koizumi; Yoshinori Ohta; Mio Sakuma; Rika Okamoto; Chisa Matsumoto; David W Bates; Takeshi Morimoto
Journal:  Drugs Real World Outcomes       Date:  2017-09

5.  Association of blood heavy metals with developmental delays and health status in children.

Authors:  Yu-Mei Hsueh; Chih-Ying Lee; Ssu-Ning Chien; Wei-Jen Chen; Horng-Sheng Shiue; Shiau-Rung Huang; Ming-I Lin; Shu-Chi Mu; Ru-Lan Hsieh
Journal:  Sci Rep       Date:  2017-03-02       Impact factor: 4.379

6.  Personal and Social Resources Are Linked to Cognition and Health-Related Quality of Life in Childhood Cancer Survivors.

Authors:  Valerie Siegwart; Kirstin Schürch; Valentin Benzing; Jochen Roessler; Regula Everts
Journal:  Children (Basel)       Date:  2022-06-22

Review 7.  Can We Compare the Health-Related Quality of Life of Childhood Cancer Survivors Following Photon and Proton Radiation Therapy? A Systematic Review.

Authors:  Mikaela Doig; Eva Bezak; Nayana Parange; Peter Gorayski; Victoria Bedford; Michala Short
Journal:  Cancers (Basel)       Date:  2022-08-15       Impact factor: 6.575

8.  The association between vincristine-induced peripheral neuropathy and health-related quality of life in children with cancer.

Authors:  Mirjam E van de Velde; Marleen H van den Berg; Gertjan J L Kaspers; Floor C H Abbink; Jos W R Twisk; Inge M van der Sluis; Cor van den Bos; Marry M van den Heuvel-Eibrink; Heidi Segers; Christophe Chantrain; Jutte van der Werff Ten Bosch; Leen Willems; Raphaële R L van Litsenburg
Journal:  Cancer Med       Date:  2021-11-01       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.